Systemic amyloidosis associated with pleomorphic sarcoma of the spleen and remission of nephrotic syndrome after removal of the tumor

被引:13
作者
Agha, I
Mahoney, R
Beardslee, M
Liapis, H
Cowart, RG
Juknevicius, I
机构
[1] Washington Univ, Sch Med, Div Renal, Carbondale, IL USA
[2] Washington Univ, Sch Med, Div Cardiol, Dept Internal Med, Carbondale, IL USA
[3] Washington Univ, Sch Med, Dept Pathol, Carbondale, IL USA
[4] Barnes Jewish Hosp, St Louis, MO 63110 USA
[5] Carbondale Clin, Carbondale, IL USA
关键词
amyloidosis; sarcoma; nephrotic syndrome (NS);
D O I
10.1053/ajkd.2002.34545
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
We report a case of a 57-year-old woman who was diagnosed with a systemic AA amyloidosis associated with a pleomorphic sarcoma of the spleen. Although the association and causality between chronic inflammatory states and systemic AA amyloidosis have been well established, the evidence linking solid malignancies to reactive AA amyloidosis Is scarce. Our patient had a significant systemic amyloid deposition including biopsy-proven renal and cardiac AA amyloidosis. Subsequent evaluation uncovered the presence of a large splenic mass, which was treated by splenectomy. Histologically the splenic tumor was classified as pleomorphic sarcoma. The removal of the tumor resulted in a marked decline in proteinuria, stable renal and cardiac functions, and symptomatic improvement at 1-year follow-up. Based on the noted improvements, we speculate that the pleomorphic sarcoma of the spleen caused secondary amyloidosis In our case. Stromal tumors, although rare, may be associated with and should be considered in the differential diagnosis of the cause of AA amyloidosis. (C) 2002 by the National Kidney Foundation, Inc.
引用
收藏
页码:411 / 415
页数:5
相关论文
共 16 条
  • [1] SERUM AMYLOID-A (SAA) VARIATIONS IN PATIENTS WITH CANCER - CORRELATION WITH DISEASE-ACTIVITY, STAGE, PRIMARY SITE, AND PROGNOSIS
    BIRAN, H
    FRIEDMAN, N
    NEUMANN, L
    PRAS, M
    SHAINKINKESTENBAUM, R
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1986, 39 (07) : 794 - 797
  • [2] BROWNING M, 1983, P EUR DIAL TRANS, V20, P595
  • [3] BUXBAUM J, 1998, RHEUMATOLOGY, P615
  • [4] Diffuse retroperitoneal amyloidosis due to renal cell carcinoma
    Coakley, FV
    Hricak, H
    Presti, JC
    Small, EJ
    [J]. BRITISH JOURNAL OF RADIOLOGY, 1999, 72 (856) : 412 - 413
  • [5] Amyloid proteins in pathogenesis of AA amyloidosis
    Cunnane, G
    [J]. LANCET, 2001, 358 (9275) : 4 - 5
  • [6] D'Antonio A, 2000, Adv Clin Path, V4, P99
  • [7] Falk R H, 2000, Adv Intern Med, V45, P107
  • [8] SYSTEMIC AMYLOIDOSIS AND OVARIAN-CARCINOMA
    FERNANDEZMIRANDA, C
    MATEO, S
    GONZALEZGOMEZ, C
    BALLESTIN, C
    [J]. POSTGRADUATE MEDICAL JOURNAL, 1994, 70 (825) : 505 - 506
  • [9] SECONDARY SYSTEMIC AMYLOIDOSIS - RESPONSE AND SURVIVAL IN 64 PATIENTS
    GERTZ, MA
    KYLE, RA
    [J]. MEDICINE, 1991, 70 (04) : 246 - 256
  • [10] Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein
    Gillmore, JD
    Lovat, LB
    Persey, MR
    Pepys, MB
    Hawkins, PN
    [J]. LANCET, 2001, 358 (9275) : 24 - 29